# Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery

> **NCT01820520** · PHASE3 · TERMINATED · sponsor: **Asociación para Evitar la Ceguera en México** · enrollment: 22 (actual)

## Conditions studied

- Macular Hole
- Epiretinal Membrane

## Interventions

- **DRUG:** brilliant blue G

## Key facts

- **NCT ID:** NCT01820520
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Undefined
- **Last updated:** 2024-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820520, "Safety and Efficacy of Double Staining With Brilliant Blue G for Macular Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01820520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*